Aurinia Pharmaceuticals Inc. SEC filings AUPH
Aurinia Pharmaceuticals Inc. has 615 filings in SEC EDGAR's recent list, going back to Feb 28, 2014. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SC TO-T/A | Filing | May 11, 2026 | — |
| SC TO-T | Filing | Apr 13, 2026 | — |
| PX14A6G | Filing | Jul 6, 2023 | — |
| PX14A6G | Filing | Jun 1, 2023 | — |
| PX14A6G | Filing | May 17, 2023 | — |
| PX14A6G | Filing | May 11, 2023 | — |
| PX14A6G | Filing | May 5, 2023 | — |
| PX14A6G | Filing | May 3, 2023 | — |
| PX14A6G | Filing | Apr 26, 2023 | — |
| SUPPL | Prospectus supplement no. 2 | Jul 23, 2020 | — |
| SUPPL | Prospectus supplement no. 2 | Jul 22, 2020 | — |
| SUPPL | Prospectus supplement no. 1 | Jun 26, 2020 | — |
| EFFECT | Filing | Jun 19, 2020 | — |
| SUPPL | Prospectus supplement no. 4 | Dec 10, 2019 | — |
| SUPPL | Prospectus supplement no. 4 | Dec 9, 2019 | — |
| SUPPL | Prospectus supplement no. 3 | Sep 13, 2019 | — |
| SUPPL | Prospectus supplement no. 2 | Nov 30, 2018 | — |
| SUPPL | Prospectus supplement no. 1 | Apr 6, 2018 | — |
| EFFECT | Filing | Mar 29, 2018 | — |
| SUPPL | Filing | Mar 14, 2017 | — |
| SUPPL | Filing | Mar 13, 2017 | — |
| SUPPL | Filing | Feb 24, 2017 | — |
| SUPPL | Suppl #4 | Dec 23, 2016 | — |
| SUPPL | Suppl #4 | Dec 22, 2016 | — |
| SUPPL | Filing | Nov 9, 2016 | — |
| SUPPL | Filing | Jul 22, 2016 | — |
| SUPPL | Filing | Jul 15, 2016 | — |
| EFFECT | Filing | Nov 5, 2015 | — |
| CERTNAS | Auto-generated paper document | Aug 28, 2014 | — |
| 40FR12B/A | Filing | Jun 19, 2014 | — |
| 40FR12B | Filing | Apr 16, 2014 | — |
| D | Filing | Feb 28, 2014 | — |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AUPH (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Edmonton, Alberta, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1600620
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.